Dana G. Jr Mead's Trading History
| LUNGPulmonx | Jun 09, 2026 | Director | Uninformative Buy | ― | $432.09K | |
| MOBIMobia Medical, Inc. | May 11, 2026 | Director | Informative Buy | 105.00K | $74.06K | |
| INSPInspire Medical Systems | May 04, 2026 | Director | Uninformative Buy | ― | $1.79M | |
| NARIInari Medical | Feb 19, 2025 | ― | Uninformative Sell | ― | $0.00 | |
| XENTIntersect ENT | May 16, 2022 | ― | Uninformative Sell | 590.14K | $0.00 | |
| TDOCTeladoc | May 13, 2016 | Director | Uninformative Buy | ― | $0.00 |
You May Also Like
Dana G. Jr Mead insider profile FAQ
What is the percentage of profitable transactions made by Dana G. Jr Mead?
The percentage of profitable transactions made by Dana G. Jr Mead is 25%.
What is the average return per transaction made by Dana G. Jr Mead?
The average return per transaction made by Dana G. Jr Mead is 10.70%.
What stocks does Dana G. Jr Mead hold?
Dana G. Jr Mead holds: LUNG, XENT, INSP, NARI, MOBI, TDOC stocks.
What was Dana G. Jr Mead's most profitable transaction?
Dana G. Jr Mead’s most profitable transaction was an Informative Buy of TDOC stock on March 18, 2016. The return on the trade was 109.10%.
What is Dana G. Jr Mead's role in Pulmonx?
Dana G. Jr Mead's role in Pulmonx is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.